Research

At B. Riley, our research process is an interactive one where we perform extensive due diligence on companies until the analyst develops the knowledge base and understanding of the company and the industry to make a recommendation. Our analysts continuously monitor industry developments and communicate with the management, competitors, suppliers and customers of the companies we follow, regularly communicating our findings through Research Updates and daily Morning Notes.

While we do not necessarily publish research on all of the companies we review, the knowledge base and understanding of many of our monitored companies parallels that of our covered companies. We actively cover over 100 companies and monitor an additional 100. Our analysts cover small to mid-cap companies that are under-followed or misunderstood by Wall Street. We believe that the pricing of small cap equities is frequently inefficient, and therefore provides the greatest potential rewards to diligent security analysis.

This Week's Research

  • 12/02/16 Update Industry Update - Semiconductors & Semi. Cap. Equipment: Unusual SOX Pullback Creates An Unusually Attractive AMAT and MCHP Entry Oppty
  • 12/02/16 Update AVGO ($162.79, Buy; $225.00 PT): Expect A Solid Print And Guide; C17’s EPS Growth Drivers Offer Compelling Catalysts
  • 12/02/16 Morning Note B. Riley AM Note: AMSWA, AVGO, GPX, III, XCRA, ZUMZ; Semiconductors & Semi. Cap. Equipment (AMAT, MCHP)
  • 12/02/16 Update ZUMZ ($23.25, Buy; $27.00 PT): Q3 EPS Exceeded, Inflection Achieved/Q4 Guide-In Line; Strong Merch. Content Driving Positive Comps Q-T-D; Slightly…
  • 12/02/16 Update XCRA ($6.42, Buy; $8.00 PT): Mixed Print But Above-Street Outlook As Product Execution Improves. PT To $8.00, Buy
  • 12/02/16 Update AMSWA ($10.20, Buy; $12.50 PT): Reports Q2 ’17 Results Below Expectations; Reducing Revenue Estimates and Price Target; Reiterate Buy Rating
  • 12/02/16 Update GPX ($27.55, Neutral; $24.00 PT): Analyst Day Highlights; Maintain Neutral Rating and $24.00 Price Target
  • 12/01/16 Update B. Riley & Co. December Focus List Update: BV, DKS, FLEX, GSM, KTOS, LITE, MPAA, MRVL, PBH, PFSW, TIVO, TNAV, TRUE
  • 12/01/16 Morning Note B. Riley AM Note: AEO, BV, GES, IVAC, MCHP, MRVL, SANM, SMTC, TLYS, TYPE; December Focus List (BV, DKS, FLEX, GSM, KTOS, LITE, MPAA, MRVL, PBH, PFSW,…
  • 12/01/16 Update GES ($13.20, Buy; $17.00 PT): Q3 Miss; Q4 Guide Below/FY Guide Down, EU and Asia Grew; Domestic Inflection Pushed Out; Lowering Estimates and PT From…
  • 12/01/16 Update AEO ($16.56, Buy; $22.00 PT): Q3 Soft Core Comp/EPS In Line; Q4 Guide-Below; Taking Market Share; GM% up Despite Backdrop; Aerie Crushing it; Improved…
  • 12/01/16 Update TLYS ($11.49, Buy; $14.00 PT): OutstandingQ3/Q4 Guide Brackets Consensus, Despite Slow Start; Ed Thomas’ Influence Building with Runway Ahead, Raising…
  • 12/01/16 Update TYPE ($19.60, Buy; $22.00 PT): Analyst Day Takeaways; Reiterate Buy Rating and $22.00 Price Target
  • 12/01/16 Update SANM ($32.85, Buy; $40.00 PT): Client Meetings with Management Suggests Improved Visibility with Optical, Industrial and Medical Customers; Introducing…
  • 12/01/16 Update SMTC ($29.00, Buy; $37.00 PT): Beats And Raises As Growth Drivers Offset Key Customer Issues; PT Remains $37.00, Buy
  • 12/01/16 Update BV ($5.30, Buy; $8.00 PT): Reports Q2 ’17 Results; Reaffirms FY ’17 Guidance; Reiterate Buy Rating and $8.00 Price Target
  • 11/30/16 Morning Note B. Riley AM Note: ACLS, AMAT, AVGO, CLX, FORM, GDDY, LRCX, MCHP, OOMA, SWKS, TUP
  • 11/30/16 Update OOMA ($9.50, Buy; $15.50 PT): OOMA Reports Record Revenue and Transitions to Positive EBITDA; Value-priced UCaaS Play Trading at 1.2x FY ’18 (Jan)…
  • 11/30/16 Update CLX ($117.69, Neutral; $123.00 PT): Raising Target P/E and Price Target from $111 to $123 Following Meeting with CEO
  • 11/30/16 Update GDDY ($36.22, Buy; $45.00 PT): Evaluating the Potential HEG Deal – Many Positives, But Need More Information on Organic Growth and Churn
  • 11/29/16 Morning Note B. Riley AM Note: AMSWA, CHKE, IDCC, IMAX, TIVO
  • 11/29/16 Update IMAX ($32.05, Buy; $41.50 PT): Reducing Q4 Box Office Projection; An IMAX-Unfriendly Slate Causing Broken Record 2016 Estimate Cuts; Remain Confident…
  • 11/29/16 Update AMSWA ($11.36, Buy; $12.50 PT): Q2 ’17 Earnings Preview; Reiterate Buy Rating and $12.50 Price Target
  • 11/28/16 Morning Note B. Riley AM Note: BV, GCO, KEM, ROG, TIVO, TUP (downgrade), XCRA; Retail Apparel (AEO, GES, TLYS, ZUMZ)
  • 11/28/16 Update Industry Update: Earnings Previews for Week of 11/28: AEO, GES, TLYS, ZUMZ; Headwinds Persisted; “Black November” Promotional Intensity; Newness/Fashion…
  • 11/28/16 Update TIVO ($20.70, Buy; $31.00 PT): Cable Industry Consolidation and ROVI/TIVO Merger Could Damper Near-Term Growth Trends; Lowering Estimates, But Upcoming…
  • 11/28/16 Update GCO ($67.30, Neutral; $65.00 PT): Cubs Win, but Boots Weak, and Footwear Trend Shift Still in Place; This Suggests an In Line Quarter to Us, Which…
  • 11/28/16 Update XCRA ($6.76, Buy; $7.75 PT): Expect In-Line Performance With Continued Product Traction; Maintain Buy, $7.75 PT
  • 11/28/16 Update ROG ($73.54, Buy; $88.00 PT): Closes Accretive DeWAL Deal, Secular Tailwinds Remain Strong; PT To $88.00
  • 11/28/16 Update KEM ($5.02, Buy; $6.50 PT): Upside Remains Despite Strong Stock Performance; Raising PT from $4.75 to $6.50 as Operations Turn the Corner
  • 11/28/16 Update BV ($5.10, Buy; $8.00 PT): Q2 ’17 Earnings Preview; Reiterate Buy Rating and $8.00 Price Target
  • 11/28/16 Update TUP ($59.28, Sell; $47.00 PT): Cutting Estimates to Reflect Post-Election Foreign Currency Devaluations, Price Target from $64 to $47 and Rating from…
  • 11/28/16 Update B. Riley & Co. Focus List Update: BV, DKS, FLEX, KTOS, LITE, MPAA, MRVL, PBH, PFSW, TIVO, TNAV, TRUE, VVI